Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure, J Am Coll Cardiol, vol.37, issue.1, pp.183-188, 2001. ,
Cardiac cell therapy-mixed results from mixed cells, N Engl J Med, vol.355, issue.12, pp.1274-1277, 2006. ,
Current state of stem cell therapy for ischemic heart disease, Curr Cardiol Rep, vol.18, issue.2, p.17, 2016. ,
Emerging therapies and future directions in pulmonary arterial hypertension, Can J Cardiol, vol.31, issue.4, pp.489-501, 2015. ,
Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol, vol.62, pp.34-41, 1925. ,
The changing landscape of pulmonary arterial hypertension and implications for patient care, Eur Respir Rev, vol.23, issue.134, pp.450-457, 2014. ,
, Representative markers of stem cells usable for right ventricle cell therapy. Pulmonary Circulation Volume, vol.8
Management of pulmonary arterial hypertension, J Am Coll Cardiol, vol.65, issue.18, pp.1976-1997, 2015. ,
Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure, J Am Coll Cardiol, vol.37, issue.1, pp.183-188, 2001. ,
Right ventricular adaptation and failure in pulmonary arterial hypertension, Can J Cardiol, vol.31, issue.4, pp.391-406, 2015. ,
The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography, Pulm Circ, vol.5, issue.1, pp.29-47, 2013. ,
The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure, Circ Res, vol.115, issue.1, pp.176-188, 2014. ,
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology, J Am Coll Cardiol, vol.62, pp.22-33, 1925. ,
Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension, Circulation, vol.131, pp.1691-1702, 2015. ,
Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure, Circulation, vol.120, issue.20, pp.1951-1960, 2009. ,
Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension, J Heart Lung Transplant, vol.32, issue.2, pp.231-240, 2013. ,
Right ventricular ischemia in patients with primary pulmonary hypertension, J Am Coll Cardiol, vol.38, issue.4, pp.1137-1142, 2001. ,
A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension, J Mol Med (Berl), vol.91, issue.11, pp.1315-1327, 2013. ,
Reverse right ventricular remodeling after lung transplantation in patients with pulmonary arterial hypertension under combination therapy of targeted medical drugs, Circ J, vol.81, issue.3, pp.383-390, 2017. ,
Isolation of whole mononuclear cells from peripheral blood and cord blood, Curr Protoc Immunol, issue.1, 2009. ,
Umbilical cord bloodderived mononuclear cells exhibit pericyte-like phenotype and support network formation of endothelial progenitor cells in vitro, Ann Biomed Eng, vol.43, issue.10, pp.2552-2568, 2015. ,
Crosstalk between stem and progenitor cellular mediators with special emphasis on vasculogenesis, Transfus Med Hemotherapy, vol.44, issue.3, pp.174-182, 2017. ,
Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload, Stem Cell Res Ther, vol.6, p.50, 2015. ,
Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood ,
, Br J Haematol, vol.147, issue.2, pp.246-261, 2009.
Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system, Stem Cells Transl Med, vol.4, issue.2, pp.195-206, 2015. ,
Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload, Cell Transplant, vol.18, issue.8, pp.855-868, 2009. ,
Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training, Ann Thorac Surg, vol.89, issue.2, pp.585-593, 2010. ,
Mesenchymal stem cells and their use in therapy: what has been achieved?, Differ Res Biol Divers, vol.85, issue.1-2, pp.1-10, 2013. ,
Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle, Grover Conference Series). Pulm Circ, vol.5, issue.1, pp.73-80, 2013. ,
Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro, Stem Cells Dev, vol.22, issue.4, pp.643-653, 2013. ,
Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications, J Immunol Res, p.394917, 2015. ,
Mesenchymal stem cells, Thorax, vol.67, issue.6, pp.565-566, 2012. ,
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC, Cell Commun Signal, vol.9, p.12, 2011. ,
Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension, Am J Physiol Heart Circ Physiol, vol.297, issue.5, pp.1606-1616, 2009. ,
The effect of umbilical cord blood derived mesenchymal stem cells in monocrotalineinduced pulmonary artery hypertension rats, J Korean Med Sci, vol.30, issue.5, pp.576-585, 2015. ,
Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism, Int Immunopharmacol, vol.14, issue.4, pp.432-437, 2012. ,
Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension, Cell Transplant, vol.21, issue.10, pp.2225-2239, 2012. ,
Intratracheal mesenchymal stem cell administration attenuates monocrotalineinduced pulmonary hypertension and endothelial dysfunction ,
, Am J Physiol Heart Circ Physiol, vol.292, issue.2, pp.1120-1128, 2007.
Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension, Circulation, vol.114, issue.1, pp.181-185, 2006. ,
Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension, Stem Cells, vol.29, issue.1, pp.99-107, 2011. ,
The therapeutic effects of human mesenchymal stem cells primed with sphingosine-1 phosphate on pulmonary artery hypertension, Stem Cells Dev, vol.24, issue.14, pp.1658-1671, 2015. ,
Right ventricular effects of intracoronary delivery of mesenchymal stem cells (MSC) in an animal model of pressure overload heart failure, Biomed Pharmacother, vol.63, issue.10, pp.767-772, 2009. ,
Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells, Circ Res, vol.103, issue.2, pp.194-202, 2008. ,
Isolation of putative progenitor endothelial cells for angiogenesis, Science, vol.275, issue.5302, pp.964-967, 1997. ,
Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress, J Appl Physiol, vol.95, issue.5, pp.2081-2088, 1985. ,
Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells ,
, Br J Clin Pharmacol, vol.68, issue.4, pp.484-492, 2009.
Circulating endothelial progenitor cells: Do they live up to their name?, Vascul Pharmacol, pp.67-69, 2015. ,
A comparison of the tube forming potentials of early and late endothelial progenitor cells, Exp Cell Res, vol.314, issue.3, pp.430-440, 2008. ,
Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses, BMC Genomics, vol.14, p.182, 2013. ,
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, Circ Res, vol.110, issue.4, pp.624-637, 2012. ,
Endothelial progenitors: a consensus statement on nomenclature, Stem Cells Transl Med, vol.6, issue.5, pp.1316-1320, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01777824
Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes, PLoS One, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01068695
Transplanted cord bloodderived endothelial precursor cells augment postnatal neovascularization, J Clin Invest, vol.105, issue.11, pp.1527-1536, 2000. ,
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model, Thromb Res, vol.141, pp.106-111, 2016. ,
Transplanted endothelial progenitor cells improve ischemia muscle regeneration in mice by diffusion tensor MR imaging, Stem Cells Int, p.3641401, 2016. ,
Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair, Int J Cardiol, vol.203, pp.498-507, 2016. ,
Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional longlasting vessels, Blood, vol.111, issue.3, pp.1302-1305, 2008. ,
Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats, Crit Care Med, vol.36, issue.3, pp.873-880, 2008. ,
Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension, Cytotherapy, vol.11, issue.4, pp.492-502, 2009. ,
Treatment of pulmonary arterial hypertension with circulating angiogenic cells ,
, Am J Physiol Lung Cell Mol Physiol, vol.301, issue.1, pp.12-19, 2011.
Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension, Am J Respir Cell Mol Biol, vol.43, issue.5, pp.546-554, 2010. ,
Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits, Circulation, vol.128, issue.9, pp.982-994, 2013. ,
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease, Circ Res, vol.96, issue.4, pp.442-450, 2005. ,
Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension, Cytotherapy, vol.15, issue.2, pp.209-223, 2013. ,
Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats, J Pharmacol Exp Ther, vol.330, issue.3, pp.718-726, 2009. ,
Heart regeneration with embryonic cardiac progenitor cells and cardiac tissue engineering, J Stem Cell Transplant Biol, vol.1, issue.1, p.104, 2015. ,
Cardiac progenitor cells for heart repair, Cell Death Discov, vol.2, p.16052, 2016. ,
Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction), J Am Coll Cardiol, vol.63, issue.2, pp.110-122, 2014. ,
Isolation and expansion of adult cardiac stem cells from human and murine heart, Circ Res, vol.95, issue.9, pp.911-921, 2004. ,
Exosomes as critical agents of cardiac regeneration triggered by cell therapy, Stem Cell Rep, vol.2, issue.5, pp.606-619, 2014. ,
Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction, Cardiovasc Res, vol.103, issue.4, pp.530-541, 2014. ,
Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction, Circ Heart Fail, vol.8, issue.2, pp.322-332, 2015. ,
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: rationale and design, Cell Transplant, vol.26, issue.2, pp.205-214, 2017. ,
Mechanisms of cell death in heart disease, Arterioscler Thromb Vasc Biol, vol.32, issue.7, pp.1552-1562, 2012. ,
Right ventricular failure secondary to chronic overload in congenital heart diseases: benefits of cell therapy using human embryonic stem cell-derived cardiac progenitors, J Thorac Cardiovasc Surg, vol.149, issue.3, pp.708-715, 2015. ,
Adipose-derived stem cells: Comparison between two methods of isolation for clinical applications, Ann Med Surg (Lond), vol.20, pp.87-91, 2017. ,
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation, vol.109, issue.10, pp.1292-1298, 2004. ,
Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo, Biochem Biophys Res Commun, vol.332, issue.2, pp.370-379, 2005. ,
The effect of human adiposederived stem cells on healing of ischemic wounds in a diabetic nude mouse model, Plast Reconstr Surg, vol.128, issue.2, pp.387-394, 2011. ,
Cardiac adipose-derived stem cells exhibit high differentiation potential to cardiovascular cells in C57BL/6 mice, Stem Cells Transl Med, vol.5, issue.2, pp.141-151, 2016. ,
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial, Am Heart J, vol.168, issue.1, pp.88-95, 2014. ,
Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats, Clin Exp Hypertens, vol.37, issue.3, pp.241-248, 2015. ,
Intratracheal administration of cyclooxygenase-1-transduced adipose tissuederived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats, Am J Physiol Heart Circ Physiol, vol.307, issue.8, pp.1187-1195, 2014. ,
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, vol.126, issue.4, pp.663-676, 2006. ,
Safe and effective cardiac regenerative therapy with human-induced pluripotent stem cells: how should we prepare pure cardiac myocytes?, Circ Res, vol.120, issue.10, pp.1558-1560, 2017. ,
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells, Cell Stem Cell, vol.15, issue.6, pp.750-761, 2014. ,
Therapeutic benefits of induced pluripotent stem cells in monocrotaline-induced pulmonary arterial hypertension, PLoS One, vol.11, issue.2, p.142476, 2016. ,
Induced pluripotency and oncogenic transformation are related processes, Stem Cells Dev, vol.22, issue.1, pp.37-50, 2013. ,
Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming, Int Heart J, vol.56, issue.1, pp.1-5, 2015. ,
Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair, Can J Cardiol, vol.30, issue.11, pp.1279-1287, 2014. ,
Cryopreservation of human stem cells for clinical application: a review, Transfus Med Hemother, vol.38, issue.2, pp.107-123, 2011. ,
Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension, Respir Med, vol.102, issue.7, pp.1073-1079, 2008. ,
Endothelial progenitor cells and pulmonary arterial hypertension, Heart Lung Circ, 2014. ,
Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease, Stem Cells Transl Med, vol.5, issue.2, pp.186-191, 2016. ,
Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials, Circulation, vol.112, issue.9, pp.150-156, 2005. ,
Comparison of transendocardial and intracoronary CD34 þ cell transplantation in patients with nonischemic dilated cardiomyopathy, Circulation, vol.128, issue.11, pp.42-49, 2013. ,
Stem cell therapy for heart failure: are arrhythmias a real safety concern?, Circulation, vol.119, issue.20, pp.2735-2740, 2009. ,
Generation and assessment of functional biomaterial scaffolds for applications in cardiovascular tissue engineering and regenerative medicine, Adv Healthc Mater, vol.4, issue.16, pp.2326-2341, 2015. ,
Bioengineering methods for myocardial regeneration, Adv Drug Deliv Rev, vol.96, pp.195-202, 2016. ,
Biomimetic materials and scaffolds for myocardial tissue regeneration, Macromol Biosci, vol.13, issue.8, pp.984-1019, 2013. ,
A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells, J Heart Lung Transplant, vol.29, issue.5, pp.574-577, 2010. ,
Intracoronary bone marrow cell application for terminal heart failure in children, Cardiol Young, vol.22, issue.5, pp.558-563, 2012. ,
Stem cell therapy and tissue engineering for correction of congenital heart disease, Front Cell Dev Biol, vol.3, p.39, 2015. ,
Regenerative therapy for hypoplastic left heart syndrome: first report of intraoperative intramyocardial injection of autologous umbilical-cord blood-derived cells, J Thorac Cardiovasc Surg, vol.149, issue.3, pp.35-37, 2015. ,
Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial, J Am Coll Cardiol, vol.49, issue.14, pp.1566-1571, 2007. ,
Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study, Pediatr Transplant, vol.12, issue.6, pp.650-655, 2008. ,
Endothelial NOsynthase gene-enhanced progenitor cell therapy for pulmonary arterial hypertension: The PHACeT Trial, Circ Res, vol.117, issue.7, pp.645-654, 2015. ,
Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial, Circ Res, vol.116, issue.4, pp.653-664, 2015. ,
Stem cell therapy for the systemic right ventricle, Expert Rev Cardiovasc Ther, vol.15, issue.11, pp.813-836, 2017. ,
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance, Circulation, vol.126, issue.11, pp.54-64, 2012. ,
Rationale and design of the first randomized, double-blind, placebocontrolled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial), Am Heart J, vol.164, issue.3, pp.285-291, 2012. ,
One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study), JACC Cardiovasc Interv, vol.2, issue.1, pp.9-16, 2009. ,
Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy, J Card Fail, vol.17, issue.4, pp.272-281, 2011. ,
Intracoronary transplantation of CD34(þ) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy, J Card Fail, vol.21, issue.2, pp.145-152, 2015. ,
Effects of transendocardial CD34 þ cell transplantation in patients with ischemic cardiomyopathy, Circ Cardiovasc Interv, vol.7, issue.4, pp.552-559, 2014. ,
Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice, Cardiovasc Res, vol.110, issue.3, pp.319-330, 2016. ,
Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1, Stem Cells Dev, 2008. ,
Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1, Eur Heart J, vol.34, issue.10, pp.782-789, 2013. ,